Your browser doesn't support javascript.
loading
Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis.
Fowler, Philip W; Gibertoni Cruz, Ana Luíza; Hoosdally, Sarah J; Jarrett, Lisa; Borroni, Emanuele; Chiacchiaretta, Matteo; Rathod, Priti; Lehmann, Sarah; Molodtsov, Nikolay; Walker, Timothy M; Robinson, Esther; Hoffmann, Harald; Peto, Timothy E A; Cirillo, Daniela Maria; Smith, Grace E; Crook, Derrick W.
Affiliation
  • Fowler PW; 2​National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
  • Gibertoni Cruz AL; 1​Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
  • Hoosdally SJ; 1​Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
  • Jarrett L; 1​Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
  • Borroni E; 3​National Mycobacterial Reference Service, National Infection Service, Public Health Laboratory Birmingham, Heartlands Hospital, Bordesley Green, Birmingham, B9 5SS, UK.
  • Chiacchiaretta M; 4​Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rathod P; 4​Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lehmann S; 3​National Mycobacterial Reference Service, National Infection Service, Public Health Laboratory Birmingham, Heartlands Hospital, Bordesley Green, Birmingham, B9 5SS, UK.
  • Molodtsov N; 5​SYNLAB Gauting and Institute of Microbiology and Laboratory Medicine, World Health OrganizationSupranational Reference Laboratory of Tuberculosis, Munich-Gauting, Germany.
  • Walker TM; 5​SYNLAB Gauting and Institute of Microbiology and Laboratory Medicine, World Health OrganizationSupranational Reference Laboratory of Tuberculosis, Munich-Gauting, Germany.
  • Robinson E; 1​Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
  • Hoffmann H; 2​National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
  • Peto TEA; 3​National Mycobacterial Reference Service, National Infection Service, Public Health Laboratory Birmingham, Heartlands Hospital, Bordesley Green, Birmingham, B9 5SS, UK.
  • Cirillo DM; 5​SYNLAB Gauting and Institute of Microbiology and Laboratory Medicine, World Health OrganizationSupranational Reference Laboratory of Tuberculosis, Munich-Gauting, Germany.
  • Smith GE; 1​Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
  • Crook DW; 6​NIHR Health Protection Research Unit in Healthcare Associated Infection, Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK.
Microbiology (Reading) ; 164(12): 1522-1530, 2018 12.
Article in En | MEDLINE | ID: mdl-30351270
M. tuberculosis grows slowly and is challenging to work with experimentally compared with many other bacteria. Although microtitre plates have the potential to enable high-throughput phenotypic testing of M. tuberculosis, they can be difficult to read and interpret. Here we present a software package, the Automated Mycobacterial Growth Detection Algorithm (AMyGDA), that measures how much M. tuberculosis is growing in each well of a 96-well microtitre plate. The plate used here has serial dilutions of 14 anti-tuberculosis drugs, thereby permitting the MICs to be elucidated. The three participating laboratories each inoculated 38 96-well plates with 15 known M. tuberculosis strains (including the standard H37Rv reference strain) and, after 2 weeks' incubation, measured the MICs for all 14 drugs on each plate and took a photograph. By analysing the images, we demonstrate that AMyGDA is reproducible, and that the MICs measured are comparable to those measured by a laboratory scientist. The AMyGDA software will be used by the Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) to measure the drug susceptibility profile of a large number (>30000) of samples of M. tuberculosis from patients over the next few years.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbial Sensitivity Tests / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Microbiology (Reading) Journal subject: MICROBIOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbial Sensitivity Tests / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Microbiology (Reading) Journal subject: MICROBIOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom